All Pharmacokinetics articles
-
NewsNew dosing data expands HIV treatment options for newborns
Newborns with HIV can now be treated with dolutegravir from the first days of life. An international clinical study identified a safe dosing regimen that produced drug levels comparable to those seen in older children and adults, helping support the FDA’s expanded approval.